Vericel (VCEL) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Vericel Corporation  (NASDAQ: VCEL)
 

Vericel Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vericel Corporation inventory turnover ratio, the Vericel Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 4.15 in the first quarter 2026, yet the ratio remained below the average, as VCEL's market remain challenging.Average inventory processing period, for the Vericel in Mar 31 2026 quarter, has decreased to 88 days, compare to 90 days, in the Dec 31 2025 quarter.

Within Healthcare sector 91 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 663 in the fourth quarter 2025, to 918.

VCEL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vericel Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VCEL Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 7.28 % 1.08 % 15.23 % 13.06 % 26.18 %
Y / Y Cost of Sales Growth 17.36 % 17.26 % 10.25 % 3.52 % 2.5 %
Inventory Turnover Ratio (TTM) 4.15 4.06 3.9 3.94 4.02
VCEL's Total Ranking # 918 # 663 # 848 # 672 # 672
Average inventory processing period 88 90 94 93 91
Seq. Inventory Growth 4.5 % -3.28 % 7.87 % -1.61 % -1.54 %
Seq. Cost of Sales Growth -3.19 % 10.45 % 7.76 % 1.85 % -3.27 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 92
Overall Market # 918

Inventory Turnover Ratio Statistics
High Average Low
15.61 6.9 3.46
(Mar 31 2016)   (Dec 31 2022)



VCEL Company Profile >> Back to VCEL Efficiency Comparisons >> Compare VCEL Inventory Turnover Ratio to its Competitors

Financial Statements
Vericel's Inventories $ 18 Millions Visit VCEL's Balance sheet
Vericel's Cost of Revenues TTM $ 73 Millions Visit VCEL's Income Statement
What are VCEL's Sales? Visit VCEL's Sales by Segment

Other Inventory Turnover Ratios
Vericel's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VCEL's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VCEL's Competitors
Inventory Turnover Ratio for VCEL's Suppliers
Inventory Turnover Ratio for VCEL's Customers

You may also want to know
VCEL's Sales Growth Rates VCEL's Pe Price to earnings ratio VCEL's Receivables Turnover Ratio VCEL's Stock Quote
VCEL's Net Income Growth Rates VCEL's Ps Price to Sales ratio VCEL's Sales per Employee VCEL's Asset Turnover Ratio
VCEL's Net Margin VCEL's Pb Price to Book ratio VCEL's Financial Strength Ratios VCEL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Infusystem Holdings Inc  10.96 $ 61.593  Millions$ 6  Millions
Irhythm Holdings Inc   10.94 $ 228.000  Millions$ 21  Millions
Earth Science Tech Inc   10.81 $ 8.224  Millions$ 1  Millions
Option Care Health Inc   10.74 $ 4,579.720  Millions$ 427  Millions
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Tarsus Pharmaceuticals Inc   7.60 $ 31.627  Millions$ 4  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions

Date modified: 2026-08-30T14:42:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.